# OnCo record nct02366884 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02366884/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02366884", "NCT02366884" ;
  schema:name "Atavistic chemotherapy: combinations of antibacterial, antifungal and antiprotozoal drugs in advanced cancer (Arguello clinic, status unknown)"@en ;
  schema:description "A private Mexican clinic registered a trial of mixtures of antibiotics, antifungals and anti-parasite drugs, ivermectin among them, in any advanced cancer. The registry has not been updated since 2022, shows no results, and lists a primary endpoint judged partly by looking at tumours."@en ;
  schema:url <https://onco.cc/trials/nct02366884/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02366884> ;
  onco:status "historic" ;
  onco:phase "2" ;
  onco:technologies <https://onco.cc/technologies/fenbendazole-ivermectin-repurposing-claims/> ;
  onco:drugs <https://onco.cc/drugs/ivermectin/>, <https://onco.cc/drugs/mebendazole/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-misinformation/> .